Skip to main content

Table 1 Baseline characteristics and clinical information of the patients

From: Feasibility and discriminatory value of tissue motion annular displacement in sepsis-induced cardiomyopathy: a single-center retrospective observational study

 

All patients

(n = 143)

SICM

(n = 26)

non-SICM

(n = 117)

p value

Age (yrs)

69 [57–78]

73 [63–83]

68 [57–77]

0.310

Gender (male, %)

94 (65.7%)

17 (65.4%)

77 (65.8%)

0.967

BMI (kg/m2)

22.9 ± 3.2

22.9 ± 3.0

22.9 ± 3.3

0.949

APACHE II score

17.1 ± 6.2

19.9 ± 6.9

16.4 ± 5.8

0.008

SOFA score

6.8 ± 2.7

8.3 ± 3.1

6.4 ± 2.5

0.007

Comorbidity (n, %)

    

Hypertension

52 (36.4%)

10 (38.5%)

42 (35.9%)

0.806

Diabetes mellitus

35 (24.5%)

8 (30.8%)

27 (23.1%)

0.409

COPD

18 (12.6%)

5 (19.2%)

13 (11.1%)

0.259

Peripheral vascular disease

8 (5.6%)

3 (11.5%)

5 (4.3%)

0.145

Cancer

22 (15.4%)

6 (23.1%)

16 (13.7%)

0.229

others

10 (7.0%)

6 (10.9%)

4 (4.5%)

0.184

Medication history (n, %)

    

β-blocker

18 (12.6%)

5 (19.2%)

13 (11.1%)

0.259

CCB

40 (28.0%)

8 (30.8%)

32 (27.4%)

0.725

ACEI / ARB

28 (19.6%)

6 (23.1%)

22 (18.8%)

0.619

Statin

12 (8.4%)

4 (15.4%)

8 (6.8%)

0.231

Septic source (n, %)

    

Abdominal

66 (46.2%)

16 (61.5%)

50 (42.7%)

0.082

Pneumonia

36 (25.2%)

9 (34.6%)

27 (23.1%)

0.220

Urinary tract

16 (11.2%)

4 (15.4%)

12 (10.3%)

0.453

Bloodstream

15 (10.5%)

4 (15.4%)

11 (9.4%)

0.368

Catheter

5 (3.5%)

1 (3.8%)

4 (3.4%)

1.0

Soft tissue

3 (2.1%)

1 (3.8%)

2 (1.7%)

1.0

Central nervous system

2 (1.4%)

1 (3.8%)

1 (0.9%)

1.0

HR (bmp)

99 ± 21

103 ± 22

96 ± 20

0.708

MAP (mmHg)

70 ± 11

64 ± 9

75 ± 11

0.126

CVP (mmHg)

9.8 ± 2.8

10.5 ± 3.1

9.3 ± 2.6

0.658

cTnT (ng/mL)

0.09 ± 0.19

0.17 ± 0.27

0.06 ± 0.07

0.002

NT-proBNP (pg/mL)

5120 ± 7687

11,910 ± 12,740

3038 ± 5147

 < 0.001

CK-MB (ng/mL)

15.5 ± 43.2

10.2 ± 10.9

5.7 ± 10.3

0.006

28d mortality (n, %)

25 (17.5%)

9(34.6%)

16 (13.7%)

0.011

In-hospital mortality (n, %)

35 (24.5%)

11 (42.3%)

24 (20.5%)

0.019

Length of ICU stay (days)

7 [3–14]

10 [3–18]

6 [3–13]

0.529

Length of hospital stay (days)

19 [6, 7, 12–28]

17 [6, 7, 12–25]

19 [6, 7, 12–29]

0.091

Duration of MV (days)

37 [12–132]

41 [16–192]

37 [12–134]

0.890

  1. BMI, body mass index; APACHE II, Acute Physiology and Chronic Health Evaluation II; SOFA, Sequential Organ Failure Assessment; COPD, chronic obstructive pulmonary disease; CCB, calcium channel blocker; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; HR, heart rate; MAP, mean arterial pressure; CVP, central venous pressure; ICU, intensive care unit; MV, mechanical ventilation; cTnT, cardiac troponin T; NT-proBNP, N-terminal pro-B type natriuretic peptide; CK-MB, creatine kinase-MB
Back to article page

Critical Care

ISSN: 1364-8535